Cardiac Biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different Disease conditions.
However, the Biomarkers that are currently in use do not reflect all the multiple Disease pathways that are involved in a broad spectrum of cardiac Disease conditions ranging from acute coronary syndrome, to Heart failure (and Heart failure with preserved ejection fraction, HFpEF), to p.
Cardiac Biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different Disease conditions